ALISON BERK: Open Payments
NPI 1215331145 · DOYLESTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$737 in 38 payments from 11 companies in 2025. Trend: 2023 $1,300 · 2024 $515 · 2025 $737
Food & beverage: $737
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $196 |
| ABBVIE INC. | 5 | $95 |
| UCB, Inc. | 4 | $87 |
| Regeneron Healthcare Solutions, Inc. | 3 | $76 |
| Incyte Corporation | 2 | $56 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $51 |
| Organon LLC | 3 | $48 |
| Botanix SB Inc | 2 | $48 |
| Novartis Pharmaceuticals Corporation | 2 | $40 |
| PFIZER INC. | 1 | $22 |
Products named: TREMFYA, Bimzelx, DUPIXENT, SKYRIZI, OPZELURA, SOFDRA, COSENTYX, ILUMYA.
Industry payments across PA — which companies pay providers there.
